YouTube2Text

Systematic Review and Meta Analysis Session Manuscript Writing | SRMA Session 6 — Transcript

by Dr Sumia - Learn Research With Us · 7,038 words · 1,201 segments · language en · Watch on YouTube

Full transcript

  1. 0:00get done.
  2. 0:02AI to write the discussion. We can take
  3. 0:03help from AI to write the intro. And
  4. 0:05even a person who has no experience of
  5. 0:08research, he will just message that I
  6. 0:10can write intro, I can write discussion,
  7. 0:11I can write this.
  8. 0:13And of course, analysis everyone thinks
  9. 0:15it's hard and methodology everyone
  10. 0:17thinks it's it's hard of course to write
  11. 0:19the whole thing.
  12. 0:21But intro, discussion everyone thinks
  13. 0:23it's very very easy thing.
  14. 0:25But the main point is that this is the
  15. 0:27most important thing for a meta.
  16. 0:29What they want from you is to make good
  17. 0:33conclusions from what you have analyzed.
  18. 0:36And a good meta analysis is one that has
  19. 0:38a good discussion.
  20. 0:40So after the whole checking, after the
  21. 0:43editors are done with checking that the
  22. 0:45all the articles are there included in
  23. 0:47the screening,
  24. 0:49analysis has been done properly or not
  25. 0:51and anything like that, their main focus
  26. 0:53is on the discussion. How have you
  27. 0:55justified that your meta is important?
  28. 0:59Okay? So we don't ignore the step, but
  29. 1:01as you guys will see, many students they
  30. 1:04use a lot of AI and that will cause that
  31. 1:07causes high AI rate
  32. 1:10and also high plagiarism. And these two
  33. 1:12things again are the things that we have
  34. 1:14to avoid. If
  35. 1:16if an article is submitted to a journal
  36. 1:18and it is it has an AI or plagiarism
  37. 1:20above 20% then it is rejected on the
  38. 1:23spot.
  39. 1:24Okay? They don't even that does not even
  40. 1:26go to the editor. It is rejected at the
  41. 1:29technical stage check.
  42. 1:31That is done by the simple process term
  43. 1:34processing. Okay? Whenever an article is
  44. 1:36published, they first just quickly check
  45. 1:38AI plagiarism and if it is more than 20%
  46. 1:41it is rejected. Okay? And the more the
  47. 1:44rejection we face, the more of course we
  48. 1:46are losing chances of getting published
  49. 1:48in a
  50. 1:49in the journals that can easily accept
  51. 1:51our article. Okay? So from the start we
  52. 1:53have try to make our article in a way
  53. 1:56that it will get published. Okay? So
  54. 1:58let's start with the manuscript I have
  55. 2:00shared with you guys some points also in
  56. 2:03the main group
  57. 2:05that you guys have to
  58. 2:07always take in your
  59. 2:09take in consideration when you are
  60. 2:10writing the manuscript.
  61. 2:12Let me see, let me go through them.
  62. 2:14[clears throat]
  63. 2:15They were suggested by the our
  64. 2:16corresponding author and he said that
  65. 2:18the article that are submitted to me,
  66. 2:20they lack all this stuff.
  67. 2:22First thing is you never add any
  68. 2:24reference in the abstract. References
  69. 2:27are there only in the intro and the
  70. 2:29discussion and sometimes in the
  71. 2:31methodology section. Okay, and
  72. 2:33references should be added in a proper
  73. 2:36format.
  74. 2:38It should be proper Vancouver style.
  75. 2:40And to do that, I have showed you guys
  76. 2:42multiple times how to go about it, how
  77. 2:44to add a reference.
  78. 2:47Sorry.
  79. 2:50Okay, how to add reference in
  80. 2:53Vancouver style?
  81. 2:55You will do like this. Let me show you.
  82. 3:01Either you copy the article and just go
  83. 3:03on to Vancouver generator and you can go
  84. 3:06for generating the link from here. Okay?
  85. 3:09And then you can by the end you will
  86. 3:11have all the articles written in the
  87. 3:14Vancouver form. Then you can get a
  88. 3:16little bit formatting done from the
  89. 3:18cloud, from cloud or any other AI
  90. 3:20software. But if you add all the
  91. 3:22references from AI softwares,
  92. 3:24it will have problems. Okay? So mostly
  93. 3:26try that to use only perplexity and and
  94. 3:30Claude for the for generating the
  95. 3:32references.
  96. 3:34Gemini, Google Scholar, Gemini and even
  97. 3:37ChatGPT, they are all they all generate
  98. 3:39fake responses. They all generate fake
  99. 3:41references.
  100. 3:42So if you are adding a fake reference,
  101. 3:43it will always get picked up. And even
  102. 3:46if you are using
  103. 3:47Claude or perplexity, you have to
  104. 3:49counter check it in a way.
  105. 3:51Sometimes [snorts]
  106. 3:52the reference that Claude has suggested,
  107. 3:55it is not what it it is stating. Okay?
  108. 3:58So you your task is made easy by AI, but
  109. 4:01what you have to do is you have to
  110. 4:02counter check this step, okay?
  111. 4:04Otherwise, these are the things that are
  112. 4:06costing
  113. 4:07a lot of articles, many problems.
  114. 4:10Okay, let me go through it. The next
  115. 4:12step
  116. 4:14You will not add any references in the
  117. 4:16abstract. Proper formatting of the
  118. 4:18references should be there. Prospero
  119. 4:20registration we will do at this stage
  120. 4:22now, okay? Abstract should be in 250 to
  121. 4:24300 words. That's the limit mostly
  122. 4:27journals they require it. AI plagiarism
  123. 4:29should be reduced below 20%. Discussion
  124. 4:32is the most critical part and you have
  125. 4:34to address it. I will share with you how
  126. 4:37to go about writing the discussion
  127. 4:39writing. Prisma flowchart you have to
  128. 4:41make properly. Okay, and I have also
  129. 4:44shared with you guys the template for
  130. 4:46the Prisma flowchart. Prisma flowchart
  131. 4:48the main problem that the students make
  132. 4:50is that that the numbers don't add up.
  133. 4:53For example, if you are saying the 200
  134. 4:55articles were screened in primary
  135. 4:57screening and 300 articles were screened
  136. 4:59in
  137. 5:01were articles screened in secondary
  138. 5:02screening, you should mention that 300
  139. 5:05articles were excluded in primary
  140. 5:07screening. The numbers should be adding
  141. 5:08up. Then if 300 articles were included
  142. 5:11in secondary screening, 100 were
  143. 5:13excluded because of wrong population, 50
  144. 5:16were excluded because of wrong
  145. 5:17intervention, 20 were excluded because
  146. 5:19of wrong outcome.
  147. 5:21Just 14 were included. But if it is not
  148. 5:24adding up, all these numbers are not
  149. 5:26adding up to 300, then that means you
  150. 5:28are making a problem.
  151. 5:30So the editor will not go and check
  152. 5:33whether 100 were wrong population or 100
  153. 5:35were wrong intervention or anything like
  154. 5:37that. But your numbers should add up.
  155. 5:40Okay? So even if there is like an up and
  156. 5:42down, of course you're not keeping that
  157. 5:45much track of the stuff. If there's an
  158. 5:47up and down, you don't know how many
  159. 5:48articles were excluded because of loss
  160. 5:50of intervention or wrong intervention,
  161. 5:52wrong population.
  162. 5:53You can just a little bit move it up and
  163. 5:56down. Like you can change it by 50 to 55
  164. 5:58or anything like that. But the numbers
  165. 6:00should add up. Okay? That's the main
  166. 6:03concern.
  167. 6:05Proper labeling and referring to the
  168. 6:06supplementary file and I have shared
  169. 6:08with you guys also
  170. 6:10a manuscript that you can use as a
  171. 6:12template.
  172. 6:14What is important is let me
  173. 6:16let me open up one manuscript.
  174. 6:19I guess I have it.
  175. 6:23Yes, this is the manuscript.
  176. 6:27Here what is the supplementary file when
  177. 6:29you go in the
  178. 6:31when you go in the result section
  179. 6:34here
  180. 6:35when you have mentioned specifically
  181. 6:37that figure one it should actually be
  182. 6:39referring to the figure one in the
  183. 6:40supplementary file and all whenever you
  184. 6:43are
  185. 6:43wherever you have mentioned the
  186. 6:45supplementary file you have to mention
  187. 6:46for example of course you are not adding
  188. 6:48the stuff here in the in the main
  189. 6:50manuscript you are adding the stuff in
  190. 6:52the supplementary file. So whenever
  191. 6:54you're talking about quality assessment
  192. 6:55you have to mention that it is mentioned
  193. 6:58in it is shown in the figure this one
  194. 7:00or figure seven
  195. 7:02figure S1 of the supplementary file then
  196. 7:05forward
  197. 7:06let me show you here they would also
  198. 7:08have mentioned it.
  199. 7:15Let me show you where else
  200. 7:19supplementary figures S10 to 11 okay so
  201. 7:22all the time you are continuously
  202. 7:24referring the supplementary files and
  203. 7:25adding the citations here. So that will
  204. 7:28make it easier for the editor to
  205. 7:31correctly check side by side from the
  206. 7:33manuscript and the supplementary file
  207. 7:35side by side okay.
  208. 7:37So proper labeling and referring to the
  209. 7:39supplementary file needs to be done. All
  210. 7:41the supplementary tables should be cited
  211. 7:44in the main manuscript okay I will tell
  212. 7:45you guys what stuff to add in the
  213. 7:47supplementary file and what to add in
  214. 7:49the main manuscript okay.
  215. 7:51Keep one parent article and try to
  216. 7:53follow it for that you can even keep
  217. 7:56for example if you are trying for mostly
  218. 7:58we target Springer journals
  219. 8:00or even you can go for any journal like
  220. 8:03related to whatever you want and you can
  221. 8:05open up any meta-analysis that they
  222. 8:07published and see how they have written
  223. 8:09it.
  224. 8:10And try to copy their pattern.
  225. 8:12Okay or at least the manuscript that I
  226. 8:14have shared with you guys in the group
  227. 8:16you can go about it that you copy the
  228. 8:18pattern of that manuscript okay.
  229. 8:21So this is the stuff that you have to
  230. 8:23keep in mind when you are writing the
  231. 8:24manuscript proper formatting should be
  232. 8:26there.
  233. 8:27So let's start. What is a good
  234. 8:29manuscript? It has a clear and exciting
  235. 8:31scientific message.
  236. 8:33It should have a logical flow.
  237. 8:36It is written in a clear and
  238. 8:37understandable language and is relatable
  239. 8:39to the reader.
  240. 8:40Once again if you are getting the things
  241. 8:41done from AI
  242. 8:43you can but just giving it a prompt help
  243. 8:45me write an intro with these many
  244. 8:47references of this topic and just copy
  245. 8:49pasting it that's not the right stuff to
  246. 8:51do.
  247. 8:52Okay you have to counter check the
  248. 8:54references you have to counter check
  249. 8:55what the content is there and what it is
  250. 8:57referring to actually.
  251. 8:59And is is it having a depth or not or is
  252. 9:02it making a good case or not?
  253. 9:05When you are writing a manuscript you
  254. 9:07write in this order. First is the title
  255. 9:10then we have the abstract
  256. 9:12then we have the intro then we have the
  257. 9:13methodology and results, discussion and
  258. 9:16conclusion.
  259. 9:17And how they are written
  260. 9:20how how you do you do a meta analysis?
  261. 9:23First of course you do methodology when
  262. 9:25you have done the screening and the risk
  263. 9:26of assessment and all that stuff you can
  264. 9:28write the methodology then you can go
  265. 9:31about results after you are done with
  266. 9:33the result writing or analysis on revman
  267. 9:35you can go about writing results. After
  268. 9:37results you will write the discussion
  269. 9:39that will be based on results.
  270. 9:41The conclusion will be based on all
  271. 9:43these three components together and
  272. 9:45especially on the discussion.
  273. 9:47The introduction is a separate part. You
  274. 9:49can start it while you are writing the
  275. 9:51intro that's totally fine and an
  276. 9:53abstract is a total summary of all these
  277. 9:55components.
  278. 9:57And then finally you decide the topic
  279. 9:59after you are done with the whole
  280. 10:01article okay but this is the format
  281. 10:03where we write the manuscript but
  282. 10:05actually it's written in this way. You
  283. 10:06cannot write the abstract
  284. 10:08before the whole article.
  285. 10:11You cannot finalize the title before the
  286. 10:13whole article is done. You cannot write
  287. 10:15discussion before the results. You
  288. 10:17cannot write the conclusions before the
  289. 10:19discussion.
  290. 10:20If you are doing that, that means you
  291. 10:22are just writing a general discussion.
  292. 10:24You are not discussing the results.
  293. 10:27You're just generally writing about the
  294. 10:28intervention and the control and the
  295. 10:30population and the outcomes.
  296. 10:33In the methodology section, it's an easy
  297. 10:35part. Okay? I will share with you guys
  298. 10:37now we'll go about it how to write the
  299. 10:39methodology. You just have to change the
  300. 10:41details according to what you have done.
  301. 10:44If you have performed any specific
  302. 10:46subgroup analysis, sensitivity analysis,
  303. 10:47you have to explain that. Okay? So
  304. 10:50starting with first thing is your search
  305. 10:52strategy.
  306. 10:54In your main manuscript, you will just
  307. 10:55write the main keywords that you have
  308. 10:58used,
  309. 10:59the main mesh words.
  310. 11:02In the full search strategy and the PICO
  311. 11:04table that we made, that will go in the
  312. 11:06supplementary file.
  313. 11:07Then how did you decided the studies?
  314. 11:10How was data extraction done? How was
  315. 11:12risk of bias done? And how was data
  316. 11:14analysis done? You have to explain all
  317. 11:16these things.
  318. 11:17Okay? It's a recipe for your research.
  319. 11:19You tell the reader exactly what you did
  320. 11:21in your systematic review
  321. 11:23with enough detail that anyone can
  322. 11:25replicate it without room for
  323. 11:28misinterpretation. Okay? Your search
  324. 11:31search strategy should be that much
  325. 11:33transparent that if somebody just copies
  326. 11:35it and pastes it on PubMed, it should
  327. 11:37generate the same articles.
  328. 11:39Okay? Even the method that you have done
  329. 11:41for data extraction, risk assessment,
  330. 11:43data analysis, study selection, it
  331. 11:45should all be as detailed as it can be.
  332. 11:48You will talk about which databases you
  333. 11:50used, any additional details, which mesh
  334. 11:52term you used, the full search string
  335. 11:55that will go in the supplementary file.
  336. 11:57I have also shared with you guys the
  337. 11:58template of the supplementary file. You
  338. 12:00can follow it along. Okay? Also, you
  339. 12:02have to mention the end date of your
  340. 12:05research. For example, which month was
  341. 12:07your research
  342. 12:09was your screening done? Okay? You don't
  343. 12:12have to go about 12th October 2026. You
  344. 12:15can just mention October 2026 or
  345. 12:18November 2026. Okay? So just that that a
  346. 12:22person if he is updating the meta
  347. 12:24analysis, he should know that you have
  348. 12:25done screening till November 2026.
  349. 12:28Okay?
  350. 12:29If you have hand searched any articles,
  351. 12:31you have to mention them. Forward
  352. 12:33citation means checking the references
  353. 12:35of the articles. You have to mention
  354. 12:37them. How many articles you found by
  355. 12:38hand searching, by forward citation,
  356. 12:41backward citation we did not.
  357. 12:44Backward citation we did, forward
  358. 12:45citation we did not do. Okay? Backward
  359. 12:47citation means checking the references.
  360. 12:49Forward citation is very hard.
  361. 12:52Forward citation actually means that you
  362. 12:54go on research gate, you open up that
  363. 12:56article and see which articles have
  364. 12:59cited that article. So it's a very hard
  365. 13:02process. Okay? We don't go about it
  366. 13:03mostly. We just go with these two steps
  367. 13:06hand searching and
  368. 13:09backward citation. Okay. Even if you
  369. 13:11don't remember all of the stuff of
  370. 13:13methodology we have discussed so far,
  371. 13:15you just have to go about copying these
  372. 13:19these paragraphs.
  373. 13:21You just have to change according to
  374. 13:23what you have done. Okay? For example,
  375. 13:25an electronic search was performed on
  376. 13:27PubMed and Base Cochrane clinical trials
  377. 13:29.gov from inception up to your time.
  378. 13:33We all used PubMed and Base Cochrane
  379. 13:36clinical trials .gov. We use these four
  380. 13:38databases.
  381. 13:39From inception means the time the
  382. 13:42articles start getting published on
  383. 13:44these databases up to which month
  384. 13:47you have done the screening.
  385. 13:49So you'll just change this time.
  386. 13:51Which mesh term you used, you will
  387. 13:53mention that.
  388. 13:54The detailed search strategy is
  389. 13:55available in the supplementary table.
  390. 13:57Okay? So the whole search strategy
  391. 13:59search strategy you will add in the
  392. 14:01supplementary file.
  393. 14:03The conference proceedings they have
  394. 14:04mentioned we checked them, then we ref
  395. 14:06checked the references of the articles.
  396. 14:08We also did forward citation. You will
  397. 14:11just mention that we did manual
  398. 14:12searching
  399. 14:14and bibliographies were searched.
  400. 14:19Now this part, references were imported
  401. 14:21to EndNote, duplicates were removed,
  402. 14:23what was your inclusion exclusion
  403. 14:24criteria, which authors did the
  404. 14:26screening?
  405. 14:27That is all summed up in this para. So
  406. 14:29this is the first para.
  407. 14:31This would be the second para of your
  408. 14:32manuscript.
  409. 14:34All of the articles were imported into
  410. 14:36EndNote. You can mention it here Ryan
  411. 14:38and duplicates were removed.
  412. 14:40Two authors just mentioned their
  413. 14:41initials, screened the titles and the
  414. 14:44abstracts.
  415. 14:45Full text of the remaining articles were
  416. 14:46reviewed against the eligibility
  417. 14:48criteria. Conflicts were discussed and
  418. 14:50resolved with the third author. You will
  419. 14:52mention the third author name or the
  420. 14:54supervisor or the mentor.
  421. 14:56Then the inclusion exclusion criteria
  422. 14:57they have mentioned. Okay? Study designs
  423. 15:00other than RCTs, animal studies and
  424. 15:03studies not reporting survival were
  425. 15:04excluded.
  426. 15:06Okay? So that means only RCTs were
  427. 15:08included.
  428. 15:09We did not apply any language
  429. 15:10restriction. You can mention that you
  430. 15:12applied the language restriction of
  431. 15:15English. Okay? But you can also mention
  432. 15:18this thing that those articles
  433. 15:20that were searched through manual
  434. 15:21searching and that needed translation we
  435. 15:23used a Google translator to get the
  436. 15:26result because sometimes when you
  437. 15:27mention that we applied a filter of
  438. 15:28English language,
  439. 15:31mostly the journals say that why that
  440. 15:33means that you missed out on many
  441. 15:35articles that were in other language.
  442. 15:37Okay? So you have to mention that those
  443. 15:40trials that were really important but
  444. 15:42they were in different languages, we
  445. 15:44translated them.
  446. 15:45Okay?
  447. 15:46So what variables were did you
  448. 15:48extracted? What were the outcomes?
  449. 15:51Events and total, mean standard
  450. 15:53deviation, how was risk assessment
  451. 15:55performed? Okay? This is the third para
  452. 15:56now.
  453. 15:58This was the second para, this was the
  454. 16:00first para.
  455. 16:01Now this is the third paragraph. If you
  456. 16:04have any more information other than
  457. 16:06this paragraph, of course you can
  458. 16:07mention it. Okay?
  459. 16:09Data extraction was done by two
  460. 16:10researchers. They have mentioned their
  461. 16:11name. In case of disagreements it was
  462. 16:13resolved by the third researcher and
  463. 16:16what data you extracted you have to
  464. 16:18mention it, what variables and what
  465. 16:20outcomes.
  466. 16:22And if those outcomes have a proper some
  467. 16:23definition or anything, you can mention
  468. 16:25that. Okay?
  469. 16:27For categorical variables,
  470. 16:30number of events and totals were
  471. 16:32extracted. For continuous outcomes,
  472. 16:34means and a deviation sample were size
  473. 16:36were extracted. You also guys did the
  474. 16:38same thing.
  475. 16:39Then this is the fourth paragraph. Two
  476. 16:41authors assess the risk of bias, that is
  477. 16:44the quality assessment using the risk of
  478. 16:45bias ROB 2 assessment tool. ROB 2
  479. 16:48assessment tool address five domains.
  480. 16:50This is all same stuff.
  481. 16:53You can just copy paste it, but of
  482. 16:54course, if you will copy paste it, it
  483. 16:56will cause plagiarism. So just change
  484. 16:57the
  485. 16:58change the words a little bit, okay?
  486. 17:01Disagreements were resolved by the third
  487. 17:02author.
  488. 17:04Then which uh model you use for
  489. 17:06analysis, if you did any subgroup
  490. 17:08analysis, you all have to mention that.
  491. 17:09Then this is the fifth paragraph about
  492. 17:12analysis.
  493. 17:13Risk ratio, mean difference were
  494. 17:14calculated. You also calculated this.
  495. 17:18[clears throat] Random effect model was
  496. 17:19used, chi-square test and heterogeneity
  497. 17:22statistics were used. This is almost the
  498. 17:25same stuff
  499. 17:26till here. Then if you have done any
  500. 17:29subgroup analysis, you will mention it
  501. 17:30here.
  502. 17:31Otherwise, it's all same.
  503. 17:34If there is any mismatch between the
  504. 17:36number of studies in the result section
  505. 17:38and the prisma flow diagram, that is
  506. 17:40very very important. So this is
  507. 17:42important in maintaining the integrity
  508. 17:44in reporting the study selection
  509. 17:45process, okay?
  510. 17:47So that is the most important thing.
  511. 17:48Then there should be no mismatch between
  512. 17:50the numbers. The numbers should be
  513. 17:52adding up.
  514. 17:53If you have mentioned we included 13
  515. 17:55articles uh
  516. 17:56in our meta analysis, then 13 articles
  517. 17:59should be there in the baseline sheet.
  518. 18:01If there is any mismatch, then it will
  519. 18:03be considered a wrong thing.
  520. 18:07Okay, [clears throat] let me open up
  521. 18:08this article.
  522. 18:09Wait a minute.
  523. 18:14Let me then show you guys uh
  524. 18:17[clears throat] result
  525. 18:23Okay. So, methodology we have done so
  526. 18:26far. Now we are on result writing. In
  527. 18:28result writing, you don't need to report
  528. 18:31everything about
  529. 18:33this was the result of this one study,
  530. 18:34the second study and all. You just have
  531. 18:37to report the major result of the whole
  532. 18:39analysis done. Okay? So how you will
  533. 18:41arrange your forest plots? You will
  534. 18:43arrange them in order of importance.
  535. 18:45Primary outcomes first and then
  536. 18:47secondary outcomes.
  537. 18:49So what are primary outcomes? Primary
  538. 18:51outcomes are those outcomes that are
  539. 18:53reported by majority of the articles.
  540. 18:56Okay? So if an article,
  541. 18:58if an outcome is reported by 10 of the
  542. 19:00studies, then that means it's a primary
  543. 19:02outcome. According to your articles, you
  544. 19:05decide your primary outcome. If all the
  545. 19:07studies are reporting one main outcome
  546. 19:09and they all are saying this is our
  547. 19:11primary outcome, then that is your
  548. 19:13primary outcome of your meta analysis.
  549. 19:15Another criteria that we keep is primary
  550. 19:18outcome is the one that is having
  551. 19:20significance and less heterogeneity.
  552. 19:22So you have to arrange in this order
  553. 19:24first significant results and less
  554. 19:27heterogeneity and then the insignificant
  555. 19:29results.
  556. 19:31Then how will you write it? Let me show
  557. 19:33you. First, how many studies are
  558. 19:35reporting it?
  559. 19:36What was the final result and any
  560. 19:38subgroup analysis if you have done?
  561. 19:40Okay.
  562. 19:42Let me show you guys here.
  563. 19:45This is the same methodology that we
  564. 19:46have
  565. 19:47gone through right now. The meta was
  566. 19:49conducted according to the PRISMA
  567. 19:51guidelines and even the PRISMA
  568. 19:53guidelines they have attached it in the
  569. 19:55supplementary file. You all have to do
  570. 19:56this too.
  571. 19:58And the Prospero number they have
  572. 19:59mentioned it here. Okay? This is the
  573. 20:01Prospero ID. When you will register on
  574. 20:03Prospero, you will be given this ID.
  575. 20:07How to register on Prospero? Let me just
  576. 20:09show you guys that too.
  577. 20:11You will open up, you will go to
  578. 20:13Prospero website.
  579. 20:16Wait a minute.
  580. 20:21You You log in.
  581. 20:26[clears throat]
  582. 20:27You will register the review.
  583. 20:30I accept the terms.
  584. 20:35It's of people and humans.
  585. 20:37It will be published on the side.
  586. 20:41What type of review are you planning?
  587. 20:43Intervention review.
  588. 20:47And then
  589. 20:50I opened it up.
  590. 20:53Okay. Now here in Prospero, they ask you
  591. 20:56all the information that you have about
  592. 20:58your manuscript, okay? What is the
  593. 21:00title? What are the details? What are
  594. 21:02the eligibility criteria? What is the
  595. 21:04inclusion criteria? Here in this case,
  596. 21:06you can take help from AI totally, okay?
  597. 21:08And even if you are taking help from AI,
  598. 21:11it is considered a better thing, okay?
  599. 21:13Because there are less chances of error.
  600. 21:15For example, if I'm doing a registration
  601. 21:17of Prospero, what I would do is I would
  602. 21:19just simply open up any AI software. I
  603. 21:22will open up Plot and I will just
  604. 21:24mention I am
  605. 21:26registering my
  606. 21:28protocol of Sarma on
  607. 21:34GABA pentane
  608. 21:39for Parkinson disease.
  609. 21:43Help me fill these domains.
  610. 21:45And it will give you almost the right
  611. 21:48stuff. You will just copy the title. You
  612. 21:49will you will write your title review
  613. 21:51title here, whatever it is.
  614. 21:53Then you will go back. You will go for
  615. 21:55review type. It's a systematic review.
  616. 21:58What what is your population? What's
  617. 21:59your rationale? What's your objectives?
  618. 22:01You have to answer all these questions,
  619. 22:03okay? This is very easy. If anyone of
  620. 22:05you when doing this Prospero
  621. 22:07registration, you face any problem, you
  622. 22:09can always ask me, okay? But this is a
  623. 22:11very easy process. You just have to go
  624. 22:13about it. It takes time. It takes 30
  625. 22:15minutes because you have to add all of
  626. 22:17this stuff, but still
  627. 22:19it's not hard, okay? Then later on,
  628. 22:24they ask you the question
  629. 22:26eligibility criteria let me see
  630. 22:30they will ask you about your population
  631. 22:31intervention control what's your
  632. 22:33timeline
  633. 22:35what's your availability you have to you
  634. 22:36can mention we don't have it okay it's
  635. 22:38totally fine
  636. 22:40how will you do the screening which
  637. 22:41outcome will you analyze which method
  638. 22:43will you use for analysis
  639. 22:46then you have to add
  640. 22:49your members these team members you
  641. 22:51don't need to add the whole team all 15
  642. 22:53members
  643. 22:54here you will just add the person who is
  644. 22:56registering the meta and the person who
  645. 22:59is a mentor okay that's it or you can
  646. 23:01add yourself and only me okay because
  647. 23:04you just want to register it we don't
  648. 23:06need to mention the names of all the
  649. 23:08authors because it becomes really hard
  650. 23:10and if even one person does not approve
  651. 23:12it it will not get published okay so we
  652. 23:15want just those people who are active to
  653. 23:17be
  654. 23:18part of these this prospero registration
  655. 23:21because this does not decide the
  656. 23:23authorship authorship is decided on the
  657. 23:26basis of when you will submit the
  658. 23:27article into the journal okay so this is
  659. 23:30again the same stuff that we just saw on
  660. 23:33the slides
  661. 23:36outcomes data extraction risk of bias
  662. 23:39data synthesis
  663. 23:42and the now we are moving off to the
  664. 23:43results writing you can guys can just
  665. 23:46copy this also you can copy this
  666. 23:48template of this
  667. 23:50meta-analysis okay you can see how they
  668. 23:53have written it and you can go about in
  669. 23:55the same way writing your whole meta
  670. 23:57the literature search retrieve how many
  671. 23:59results first they have mentioned this
  672. 24:01thing in the results after the removal
  673. 24:03of duplicates reviews
  674. 24:05we had a total of just 11 rcts okay
  675. 24:09and they have made this prisma diagram
  676. 24:11you can see how neatly they have made it
  677. 24:13records identified records removed
  678. 24:16duplicate records then primary screening
  679. 24:19done how many were removed
  680. 24:21how many were sought
  681. 24:23those that were not available as full
  682. 24:25articles and then secondary screening
  683. 24:29what's the reason for exclusion and then
  684. 24:31final thing.
  685. 24:33Okay, so in this way, your whole prisma
  686. 24:35checklist should be made and this should
  687. 24:37be made by the person who was very
  688. 24:38actively involved in the screening
  689. 24:40process.
  690. 24:42Then then the next paragraph on the
  691. 24:43results would be about the baseline
  692. 24:45characteristics.
  693. 24:47All of the studies were published
  694. 24:48between this to this timeline. What was
  695. 24:51the location? What was the site?
  696. 24:54What was the intervention?
  697. 24:56And what was the control? What else
  698. 25:00we have here
  699. 25:02what was the setting
  700. 25:04and any different thing about the study
  701. 25:06like a monitored acute care unit was
  702. 25:08used and anything like that. The first
  703. 25:10paragraph, the baseline sheet about the
  704. 25:11baseline sheet and then they have
  705. 25:13mentioned the detailed baseline sheet is
  706. 25:16shown in table one and they have added
  707. 25:18the table baseline sheet here.
  708. 25:20Okay. Then there the paragraph is on
  709. 25:23quality assessment. You can see here
  710. 25:25that they are not going into too much
  711. 25:27detail. They have just mentioned risk of
  712. 25:29bias was conducted using ROB two
  713. 25:32and we found high risk of bias in three
  714. 25:34studies and some concern in six studies.
  715. 25:37The most common issue was this
  716. 25:40and the remaining two RCTs were low
  717. 25:41risk.
  718. 25:42That's it.
  719. 25:44And then they have mentioned the
  720. 25:45supplementary file that you if you want
  721. 25:47further info, you can go go and search
  722. 25:49that. Okay, you can look at that the
  723. 25:52whole ROB assessment table.
  724. 25:55From here, the results are actually
  725. 25:56starting results and the primary
  726. 25:58outcomes. So first thing, how many
  727. 26:01studies are reporting it? Okay.
  728. 26:03That was the first thing. Wait a minute.
  729. 26:05Where was it?
  730. 26:10Number of studies reporting that
  731. 26:11outcome.
  732. 26:13All 11 studies reported the need of
  733. 26:14intubation as an outcome. So that's why
  734. 26:16this is a primary outcome. Okay. Then
  735. 26:19what was the result? What was the risk
  736. 26:21ratio?
  737. 26:22They have mentioned the patients in the
  738. 26:24APB group were at a lower risk of
  739. 26:27needing intubation as compared to the
  740. 26:29control group.
  741. 26:30Why? Because the risk ratio is less than
  742. 26:32one.
  743. 26:33I told you guys even in the last lecture
  744. 26:35that if the risk ratio is equal to one,
  745. 26:38that means there is no difference
  746. 26:39between the intervention and the control
  747. 26:41group.
  748. 26:42the risk ratio is less than one, that
  749. 26:44means the intervention group has a lower
  750. 26:47risk
  751. 26:48of that outcome as compared to the
  752. 26:49control group.
  753. 26:51Okay? And if it is more than one, that
  754. 26:53means that the intervention has a higher
  755. 26:55risk.
  756. 26:57Then they have mentioned the confidence
  757. 26:58interval, the p value and heterogeneity.
  758. 27:01That's it.
  759. 27:02Okay? You are not applying the eggers
  760. 27:04test that is a test that is applied on
  761. 27:07our software. So we have not applied it.
  762. 27:09So we will just exclude it for now this
  763. 27:11line.
  764. 27:12You will move on to this line.
  765. 27:14Grade assessment was done and this
  766. 27:16outcome was found judged to be moderate
  767. 27:18with concerns about this. Okay? So
  768. 27:21alongside the outcome they have
  769. 27:22mentioned the grade assessment.
  770. 27:24Okay? The last lecture was on quality
  771. 27:26assessment and grade assessment. If you
  772. 27:28guys have watched it, you will be
  773. 27:29knowing this thing that quality
  774. 27:30assessment we do of each study
  775. 27:33and grade assessment we do of each
  776. 27:34outcome.
  777. 27:35So along the outcome they have mentioned
  778. 27:37the grade. Okay? And then they have
  779. 27:39added the forest plot.
  780. 27:44Wait a minute. Sorry.
  781. 27:47[laughter]
  782. 27:52Wait a minute. Let me just message.
  783. 27:55Okay. Then if if you have performed any
  784. 27:58subgroup analysis, you will mention
  785. 27:59here. Otherwise move on to the next
  786. 28:02outcome, mortality.
  787. 28:0311 studies reported this mortality. What
  788. 28:06was the mortality? It was less than zero
  789. 28:09it was 0.93. So it was almost equal to
  790. 28:12one. So it was you can say it is
  791. 28:14balanced between the intervention and
  792. 28:15the control group. Okay? It's not like
  793. 28:17that the intervention has a lower risk.
  794. 28:20Okay? And then what was the grade
  795. 28:21assessment?
  796. 28:23You can see how they have very nicely
  797. 28:25referred to the supplementary file
  798. 28:28at each step. Okay? Then the forest plot
  799. 28:30they have added it. Then if you have
  800. 28:32performed any subgroup analysis, you
  801. 28:34will mention it here.
  802. 28:35Here, you can see in the secondary
  803. 28:37outcomes, they are not going into too
  804. 28:40much detail.
  805. 28:41They are just they don't even add the
  806. 28:44forest plots. Only the forest plots of
  807. 28:46the primary outcomes are added in in the
  808. 28:48main manuscript. The forest plots of the
  809. 28:50secondary outcomes, they all go in the
  810. 28:53supplementary file.
  811. 28:55Okay, for the secondary outcome, you
  812. 28:57don't go for doing
  813. 28:59writing the
  814. 29:00adding the forest plot because that will
  815. 29:02make your article very long.
  816. 29:06Okay, let's go back.
  817. 29:08[clears throat]
  818. 29:09So just the number of studies reporting
  819. 29:10that outcome, what was the result, and
  820. 29:13grade assessment, and if you have
  821. 29:15performed any subgroup analysis, okay?
  822. 29:20Also four point
  823. 29:23grade assessment of that outcome.
  824. 29:35Okay, now let's move on.
  825. 29:39So now this is about the discussion.
  826. 29:41Okay, so so far for the methodology, you
  827. 29:43just have to change the words and to
  828. 29:45write replace it with what you have
  829. 29:47done.
  830. 29:48Okay, analysis is very hard is very
  831. 29:50easy. Doing analysis is a hard work, but
  832. 29:53writing it is very easy. You just have
  833. 29:55to write how many studies are reporting
  834. 29:56it, what is the final result, and what's
  835. 29:59the grade assessment of it. That's it.
  836. 30:00Okay. So now the most important thing is
  837. 30:03the discussion writing.
  838. 30:04In discussion writing, you discuss each
  839. 30:07and every outcome in detail.
  840. 30:09And you have to repeat this whole thing
  841. 30:12for each outcome.
  842. 30:14Okay.
  843. 30:15First, if there is any previous Sharma
  844. 30:17or you are doing an updated Sharma, you
  845. 30:19will have to compare with that.
  846. 30:20Okay. Then compare with the main
  847. 30:22clinical trial. For example, mortality.
  848. 30:25I am discussing first outcome,
  849. 30:27mortality.
  850. 30:28I will see if how will I compare it with
  851. 30:30the main clinical trials. The same
  852. 30:32trials that you have included in your
  853. 30:34Sharma, you will mention that this trial
  854. 30:37done by this person they mentioned that
  855. 30:39mortality is better in the intervention
  856. 30:42group as compared to the control group.
  857. 30:44But this another trial that was done by
  858. 30:46the other person he mentioned something
  859. 30:49else okay so whatever they the trials
  860. 30:52talked about that outcome you have to
  861. 30:54mention it here.
  862. 30:55Okay and if the previous sarma is there
  863. 30:57you will have to talk what they talked
  864. 30:58about this outcome.
  865. 31:00So first in a way you are just stating
  866. 31:02that this was our result
  867. 31:04but this was the different opinions of
  868. 31:06the different trials on this outcome.
  869. 31:09If you can find any reason of why is
  870. 31:12there a difference in the findings of
  871. 31:13these different trials that have been
  872. 31:15conducted you will mention it.
  873. 31:17If you will comment if you can find any
  874. 31:19mechanism you can mention it.
  875. 31:22How will this help in policy and
  876. 31:24practice okay pick the most important
  877. 31:27finding and then repeat this whole thing
  878. 31:29for example the main thing you have to
  879. 31:31do is
  880. 31:33bring the data from the main trials
  881. 31:36what they are talking about it okay and
  882. 31:37you can do this from your extraction
  883. 31:40sheet let us go back and see one
  884. 31:42outcome.
  885. 31:45For example in the first paragraph they
  886. 31:47have just summarized the whole analysis.
  887. 31:50The results show a reduction in the risk
  888. 31:52of intubation with the intervention
  889. 31:54group as compared to the control group.
  890. 31:56For other outcome this was comparable
  891. 31:59the setting was this and that so in in a
  892. 32:01way
  893. 32:02they're just summarizing all the
  894. 32:03outcomes in the first paragraph but now
  895. 32:05here they are starting the first
  896. 32:07outcome.
  897. 32:09Prone positioning improves oxygen
  898. 32:11delivery and reduce mortality
  899. 32:14in patients on mechanical ventilation.
  900. 32:17Then they have explained the mechanism
  901. 32:19why does this happen okay and then
  902. 32:22firstly they have just explained the
  903. 32:24whole mechanism why this happens okay
  904. 32:26now they are bringing up each trial
  905. 32:29separately our results which are
  906. 32:31influenced by the meta by this person
  907. 32:34were consistent with the reduction in
  908. 32:36the risk of intubation.
  909. 32:38A similar previous meta-analysis was
  910. 32:40done and they mentioned this thing.
  911. 32:42Okay? And it was another meta-analysis
  912. 32:45and they mentioned this thing.
  913. 32:46We only included RCTs to remove
  914. 32:49confounding. Then another trial, again
  915. 32:52they are mentioning another trial.
  916. 32:54So in this way you have to do about it.
  917. 32:57And you can see that this is not
  918. 32:59something that AI can write. Yes, you
  919. 33:01can take help from AI to write the
  920. 33:03stuff, but at the end of the day you
  921. 33:05have to go back and check the articles
  922. 33:07yourself. Okay? Otherwise
  923. 33:09AI can just make the things very wrong.
  924. 33:12So this is how you will repeat it for
  925. 33:15each outcome.
  926. 33:16You will first quickly
  927. 33:18summarize the whole analysis
  928. 33:21in in one paragraph, not mentioning the
  929. 33:23numbers, just writing
  930. 33:25intervention was better if with regards
  931. 33:27to these outcomes and not with regards
  932. 33:29to these outcomes. Okay? And then you
  933. 33:32will compare with the previous
  934. 33:33systematic reviews and you will compare
  935. 33:35with the previous clinical trials. And
  936. 33:37if you can bring out any reason for
  937. 33:39this, sorry I
  938. 33:41I have joined again. Okay.
  939. 33:43Then after writing the methodology,
  940. 33:46results, discussion,
  941. 33:48discussion writing should be taken up by
  942. 33:51three to four persons. Result writing
  943. 33:53can be done by two persons. Even
  944. 33:55methodology can be written by two
  945. 33:56persons. Okay? But discussion three to
  946. 33:58four people should take it.
  947. 34:00Then final limitations, conclusions,
  948. 34:02even just a single person can do it.
  949. 34:04Be honest in mentioning the limitations
  950. 34:06which could affect your results. Okay?
  951. 34:09But you don't have to point out the
  952. 34:11limitations of yourself.
  953. 34:13For example, if you say that we did not
  954. 34:15do screening properly,
  955. 34:17of course you are giving a point to the
  956. 34:18editor.
  957. 34:19They will say you should have done it.
  958. 34:21We included only English studies.
  959. 34:23That is a limitation that you could have
  960. 34:26controlled. Okay? So you don't have to
  961. 34:27mention your limitation. You have to
  962. 34:30mention the limitation of the studies.
  963. 34:32You can mention if they had done a
  964. 34:34longer follow-up time.
  965. 34:36If the patients were compared with a
  966. 34:39control group or placebo,
  967. 34:41if the population was more
  968. 34:42heterogeneous, if we had a
  969. 34:46trial with more sample size, that would
  970. 34:48be a good limitation. Okay, this is
  971. 34:50giving a way forward
  972. 34:52to the article, to the meta analysis,
  973. 34:54limitations in the review process
  974. 34:55itself.
  975. 34:56And also try if you are mentioning any
  976. 34:59mistake that you have done, then try to
  977. 35:01mention the steps that you have taken to
  978. 35:03overcome them.
  979. 35:06In the conclusion, final conclusion,
  980. 35:08just write a quick para
  981. 35:10finalizing the whole analysis and the
  982. 35:12discussion. Okay, it will just mention
  983. 35:15that the intervention was better as
  984. 35:17compared to the control in these these
  985. 35:19outcomes and not good in these outcomes.
  986. 35:21Okay.
  987. 35:23Then the introduction writing.
  988. 35:24Introduction writing is an easy part,
  989. 35:26but once again, this is a part that is
  990. 35:28like that comes
  991. 35:30at the top of the whole manuscript.
  992. 35:32Should be written in a very proper way
  993. 35:34that it it is able to grab the attention
  994. 35:36of the
  995. 35:38editor.
  996. 35:39Your most important thing of your
  997. 35:41introduction is to convince them that
  998. 35:43your meta analysis is important.
  999. 35:46Okay, even if you are doing an updated
  1000. 35:48meta analysis in your introduction, you
  1001. 35:50should be able to convince the other
  1002. 35:52person that your meta analysis is
  1003. 35:54important for the research world. Okay.
  1004. 35:57So first you will describe your
  1005. 35:58population.
  1006. 36:00Then you will describe what is already
  1007. 36:02known, your control group,
  1008. 36:04what is unknown, what is the
  1009. 36:06intervention you are bringing, and then
  1010. 36:08we have the rationale. Okay. So what is
  1011. 36:11known? That is the procedure that is
  1012. 36:13already being used.
  1013. 36:14For example, any drug that's already
  1014. 36:16being used, for example, your control
  1015. 36:17group
  1016. 36:18that you are comparing against.
  1017. 36:20Of course, that control group, that drug
  1018. 36:23has been used for a long period of time.
  1019. 36:25So there should be something good in it.
  1020. 36:27So you will first cover it that it it
  1021. 36:28was a good drug and it it helped in this
  1022. 36:31this this regard, but it was not good
  1023. 36:33for treating AKI or anything like that.
  1024. 36:36Okay. And then you will move on to your
  1025. 36:38intervention. But this drug that is a
  1026. 36:40new drug,
  1027. 36:41it it has less side effects and it's
  1028. 36:43better or anything like that. You have
  1029. 36:45to cover it like that. Focus on your
  1030. 36:47treatment of choice, any efficacy and
  1031. 36:49safety data and highlight the knowledge
  1032. 36:51gap.
  1033. 36:53In a way again introduction five
  1034. 36:55paragraphs
  1035. 36:56population, intervention, control,
  1036. 36:59rationale.
  1037. 37:01And if you are updating your meta then
  1038. 37:03you in your rationale you have to
  1039. 37:05explain why is your meta important if
  1040. 37:08you are updating it.
  1041. 37:10What is different in this meta from the
  1042. 37:12previous meta? Okay.
  1043. 37:15In the supplementary file all the thing
  1044. 37:17all this stuff will go.
  1045. 37:19It will contain all the extra tables and
  1046. 37:21figures. Your prisma checklist will go
  1047. 37:23in the supplementary file. Your complete
  1048. 37:25search string will go in the
  1049. 37:26supplementary file. Any subgroup
  1050. 37:29analysis, sensitivity analysis you have
  1051. 37:30performed that will go in the
  1052. 37:32supplementary file. Only the main forest
  1053. 37:34plot will be in the main manuscript and
  1054. 37:35only of the primary outcome.
  1055. 37:38The forest plot of the secondary
  1056. 37:39outcomes will go in the supplementary
  1057. 37:41file.
  1058. 37:42Quality assessment, grade assessment it
  1059. 37:44will all go in the supplementary file.
  1060. 37:46Okay.
  1061. 37:48Then we have the abstract. It provides a
  1062. 37:50brief overview of the studies
  1063. 37:52objectives, methods, results and
  1064. 37:54conclusion allowing the readers to
  1065. 37:56quickly grasp the key concept. It can be
  1066. 37:58structured and unstructured.
  1067. 38:00For example, structured means you are
  1068. 38:02giving headings background, methodology,
  1069. 38:05results, discussion, conclusion.
  1070. 38:06Unstructured means you are not giving
  1071. 38:09any headings.
  1072. 38:11Then your title it will follow the full
  1073. 38:13pico format. It should not be like a
  1074. 38:15very catchy thing. It should be just
  1075. 38:17explaining what is your population, what
  1076. 38:19is your intervention, what is your
  1077. 38:21control and what are the outcomes.
  1078. 38:23So it should be a concise, clear and
  1079. 38:25informative. We will just write
  1080. 38:27the efficacy or the role of this drug in
  1081. 38:33AKI patients
  1082. 38:34in improving patient survival.
  1083. 38:37A meta-analysis of randomized controlled
  1084. 38:40trials or cohort studies whatsoever you
  1085. 38:42have done.
  1086. 38:45Don't exaggerate the novelty of your
  1087. 38:46results. Do not use words like
  1088. 38:48groundbreaking, first ever, and all that
  1089. 38:51stuff. Just prior to our knowledge, it
  1090. 38:53there has been no previous
  1091. 38:55meta-analysis on this topic.
  1092. 38:58Don't use informal language. Don't don't
  1093. 39:01use any difficult language. For example,
  1094. 39:02mostly when you try to get it done from
  1095. 39:04AI, it's a very hard language. Don't do
  1096. 39:06that.
  1097. 39:07Spelling and grammatical mistakes are
  1098. 39:09totally non not tolerable.
  1099. 39:11So even in that case, you can use AI to
  1100. 39:14correct the spelling and the grammatical
  1101. 39:15mistake, but you have to get it done.
  1102. 39:18Make an outline first, explain each word
  1103. 39:21into three or four points, and then
  1104. 39:23write away. Okay? Just let's go for a
  1105. 39:25quick
  1106. 39:27recap of the stuff
  1107. 39:28and then you guys will
  1108. 39:30we will go for ending the session.
  1109. 39:33First thing, the title. Okay, you can
  1110. 39:35see here this was their intervention.
  1111. 39:37Awake prone positioning for
  1112. 39:39non-intubated COVID-19 patient with
  1113. 39:41respiratory failure,
  1114. 39:43a meta-analysis of randomized controlled
  1115. 39:45trials. Okay? Then introduction
  1116. 39:48abstract. This is a structured abstract
  1117. 39:51because they are giving headings.
  1118. 39:55And if you are not giving if you are not
  1119. 39:57having if you are if the general
  1120. 39:59requires writing a non-structured
  1121. 40:01abstract or unstructured abstract, in
  1122. 40:03that case you will not give headings.
  1123. 40:04Okay? So firstly, they have explained
  1124. 40:07the intro.
  1125. 40:08You can see how they have done it. Then
  1126. 40:10you will write the methodology.
  1127. 40:13Then you will write the results.
  1128. 40:16And then we will have conclusions and
  1129. 40:19that's it.
  1130. 40:20Then we have come onto the introduction
  1131. 40:22section. First you see they have
  1132. 40:24explained COVID-19, the population.
  1133. 40:27Then they have explained
  1134. 40:29what is their intervention that they are
  1135. 40:31bringing in.
  1136. 40:32Then the studies have been conducted to
  1137. 40:34found and it was found that it was
  1138. 40:36feasible.
  1139. 40:37Because they are updating it, so they
  1140. 40:40have mentioned the previous systematic
  1141. 40:42reviews.
  1142. 40:43They were not having that much good
  1143. 40:44trials. There has been a new trial and
  1144. 40:47it has not been covered. So that's why
  1145. 40:49we are doing an updated meta-analysis.
  1146. 40:52Methodology, results, and discussion we
  1147. 40:54have seen. Then we have at the end
  1148. 40:57conclusion and meta-analysis showed that
  1149. 40:59this intervention lowers the risk of
  1150. 41:01intubation just quickly summarizing the
  1151. 41:03whole
  1152. 41:05analysis and the discussion part.
  1153. 41:07Then they have attached a supplementary
  1154. 41:09file and you can even take help from
  1155. 41:12this supplementary file to see the
  1156. 41:13template.
  1157. 41:15Okay, and that's it
  1158. 41:18for the whole thing. So manuscript
  1159. 41:20writing will take some time, but if you
  1160. 41:22guys will have a good
  1161. 41:24group effort, then it won't take that
  1162. 41:26much time. Okay? So but try to do, try
  1163. 41:29to have a good quality manuscript. Okay?
  1164. 41:32Because this is the thing that will go
  1165. 41:33forward. Nobody can see how you did the
  1166. 41:35screening. Nobody can see how you did
  1167. 41:37the analysis. But if you are able to
  1168. 41:39explain in your methodology, in your
  1169. 41:40results, in your discussion, how you
  1170. 41:42have done, how you have put effort into
  1171. 41:44this topic, then that will show. Okay?
  1172. 41:47Let me know if you have any question.
  1173. 41:52[clears throat]
  1174. 42:05Wait a minute.
  1175. 42:20No question, then you guys can start
  1176. 42:22writing it. Your coordinators will
  1177. 42:24create a poll
  1178. 42:25in the group and you guys have to choose
  1179. 42:27which whichever you are taking. Of
  1180. 42:29course, those people who are taking the
  1181. 42:30discussion, their contribution is
  1182. 42:32higher.
  1183. 42:33If you are taking methodology, your your
  1184. 42:35task is a little bit easier. Result
  1185. 42:37writing is a hard thing. Introduction
  1186. 42:39writing is not that hard. Okay? So in a
  1187. 42:42way, I guess if they would divide it
  1188. 42:43like this thing, two for intro, two for
  1189. 42:45methodology, four for discussion, and I
  1190. 42:47guess two for result writing.
  1191. 42:48Supplementary file making is a very hard
  1192. 42:51task. okay? So those tasks that require
  1193. 42:53more effort, of course, they would be
  1194. 42:55having a more
  1195. 42:57credit to the contributions.
  1196. 43:00So you all have to keep the points that
  1197. 43:03I have mentioned in the group in your
  1198. 43:05mind and that was it for today's
  1199. 43:07session.
  1200. 43:09I guess let's go for ending it. Thank
  1201. 43:11you so much for attending. Allah Hafiz.

About this transcript

This page contains the full transcript of Systematic Review and Meta Analysis Session Manuscript Writing | SRMA Session 6 by Dr Sumia - Learn Research With Us, generated from the public captions YouTube serves with the video. The transcript has 7,038 words across 1,201 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.

What you can do with it

Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to choose a caption track available on the video.

Free YouTube transcript tool

YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, caption language selection, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.